This inventor holds 33 USPTO granted patents and 7 published patent applications and 4 EPO patents, primarily in Body Weight Disorders. Top assignees: Millennium Pharmaceuticals Limited, Rhythm Pharmaceuticals, Inc., Millenium Pharmaceuticals, Inc.. Active years: 1997-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Waterstown, MA (US) (1998 - 1999)
- Cambridge, MA (US) (2003)
- Watertown, MA (US) (1997 - 2009)
- Newton, MA (US) (2001 - 2023)
Company Filing History:
21 out of 855 
5 out of 12 
2 out of 36 
Years Active: 1997-2026
Areas of Expertise:
Title: Innovations of Louis Anthony Tartaglia in Melanocortin-4 Receptor Research
Introduction
Louis Anthony Tartaglia is a prominent inventor based in Watertown, MA, known for his significant contributions in the field of medical science. He holds an impressive portfolio of 32 patents, showcasing his commitment to innovation and improving therapeutic methods for various disorders.
Latest Patents
Among his latest inventions are patents related to the treatment of melanocortin-4 receptor-associated disorders in heterozygous carriers. These methods involve administering an effective amount of an agonist of the melanocortin-4 receptor (MC4R) to subjects who are heterozygous carriers of an MC4R mutation. This innovative approach aims to address disorders resulting from an attenuated response of MC4R to α-melanocortin stimulating hormone (α-MSH).
Career Highlights
Tartaglia has made a notable impact in the pharmaceutical industry through his work in companies such as Millennium Pharmaceuticals Limited and Rhythm Pharmaceuticals, Inc. His role in these organizations reflects his dedication to advancing medical sciences and ensuring the implementation of his patented methods in therapeutic settings.
Collaborations
Throughout his career, Louis Anthony Tartaglia has collaborated with esteemed professionals, including Robert I. Tepper and Janice A. Culpepper. These partnerships further exemplify the collaborative nature of scientific research and innovation.
Conclusion
Louis Anthony Tartaglia's innovations, especially in the realm of melanocortin-4 receptor disorders, demonstrate his significant role as an inventor and a contributor to the medical field. His continuous efforts and groundbreaking patents pave the way for future advancements in treatment strategies, benefiting countless individuals affected by such disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile